Researcher
Quentin Van Thillo
- Disciplines:Systems biology
Affiliations
- Laboratory of Molecular Biology of Leukemia (VIB-KU Leuven) (Division)
Member
From1 Oct 2018 → Today
Projects
1 - 1 of 1
- Cooperation of TLX3 with epigenetic changes in the development of T-cell acute lymphoblastic leukemiaFrom1 Oct 2018 → 20 Oct 2022Funding: FWO fellowships
Publications
1 - 8 of 8
- Revisiting a case of idiopathic hypereosinophilic syndrome with novel molecular techniques identifies a second case of a myeloid/lymphoid neoplasm with a SART3::PDGFRB fusion(2023)
Authors: Quentin Van Thillo, Barbara Dewaele, Jolien De Bie, Lucienne Michaux, Timothy Devos, Peter Vandenberghe
Pages: E7 - E10 - Aberrant MYCN expression drives oncogenic hijacking of EZH2 as a transcriptional activator in peripheral T-cell lymphoma(2022)
Authors: Marlies Vanden Bempt, Koen Debackere, Sofie Demeyer, Quentin Van Thillo, Nienke Meeuws, David Nittner, Thomas Tousseyn, Jan Cools, Daan Dierickx
Pages: 2463 - 2476 - Modulation of thromboinflammation in hospitalized COVID-19 patients with aprotinin, low molecular weight heparin, and anakinra: The DAWn-Antico study(2022)
Authors: Quentin Van Thillo, Iwein Gyselinck, Caroline Martens, Joost Wauters, Jan Gunst, Carine Wouters, Christophe Vandenbriele, Steffen Rex, Laurens Liesenborghs, Alexander Wilmer, et al.
- Oncogenic cooperation in T-cell acute lymphoblastic leukemia: the role of TLX3 and TCF7-SPI1(2022)
Authors: Quentin Van Thillo, Jan Cools, Charles De Bock
- Early high antibody titre convalescent plasma for hospitalised COVID-19 patients: DAWn-plasma(2022)
Authors: Timothy Devos, Quentin Van Thillo, Iwein Gyselinck, Piet Maes, Laurens Liesenborghs, Ann Belmans, Peter Verhamme, Geert Meyfroidt
- Oncogenic cooperation between TCF7-SPI1 and NRAS(G12D) requires β-catenin activity to drive T-cell acute lymphoblastic leukemia(2021)
Authors: Quentin Van Thillo, Jolien De Bie, Sofie Demeyer, Heidi Segers, Nancy Boeckx, Anne Uyttebroeck, Jan Cools
- A randomized, open-label, adaptive, proof-of-concept clinical trial of modulation of host thromboinflammatory response in patients with COVID-19: the DAWn-Antico study (vol 21, 1005, 2020)(2020)
Authors: Thomas Vanassche, MM Engelen, Quentin Van Thillo, Jan Gunst, Carine Wouters, Christophe Vandenbriele, Steffen Rex, L Liesenborghs, Alexander Wilmer, P Meersseman, et al.
- A randomized, open-label, adaptive, proof-of-concept clinical trial of modulation of host thromboinflammatory response in patients with COVID-19: the DAWn-Antico study(2020)
Authors: Thomas Vanassche, Quentin Van Thillo, Joost Wauters, Jan Gunst, Carine Wouters, Christophe Vandenbriele, Steffen Rex, Laurens Liesenborghs, Alexander Wilmer, Greet Van den Berghe, et al.